Envista Holdings (NVST) Income from Continuing Operations (2018 - 2026)
Envista Holdings (NVST) recorded quarterly Income from Continuing Operations of 38700000.0 in Q2 2026, up 17.63% quarter-over-quarter from 32900000.0 in Q4 2025, and up 115.0% on a YoY basis from 18000000.0 in Q2 2025.
Envista Holdings (NVST) Income from Continuing Operations (2018 - 2026) Analysis & Trends
Envista Holdings' Income from Continuing Operations history runs 9 years deep, the most recent figure standing at 38700000.0 for Q2 2026.
- In Q2 2026, Income from Continuing Operations rose 115.0% year-over-year to 38700000.0; the TTM figure through Apr 2026 stood at 67700000.0 (up 106.02% YoY), while the FY2025 annual figure was 47000000.0, up 104.2% from the prior year.
- Income from Continuing Operations was 38700000.0 for Q2 2026 at Envista Holdings, up from 32900000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 73500000.0 in Q4 2022 to a low of 1151600000.0 in Q2 2024.
- Historically, Income from Continuing Operations has averaged 52652941.18 across 5 years, with a median of 26400000.0 in 2025.
- The sharpest annual moves came in 2024 and 2025: Income from Continuing Operations slumped 2318.88% in 2024, then soared 2641.67% in 2025.
- A 5-year view of Income from Continuing Operations shows it stood at 73500000.0 in 2022, then tumbled by 395.78% to 217400000.0 in 2023, then jumped by 100.55% to 1200000.0 in 2024, then jumped by 2641.67% to 32900000.0 in 2025, then grew by 17.63% to 38700000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 38700000.0 (Q2 2026), 32900000.0 (Q4 2025), and 30300000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 147.79 Bn | 143.40 Bn | 1.83 Bn | 826.00 Mn |
| 2 | Becton Dickinson | 41.23 Bn | 40.22 Bn | 2.15 Bn | -37.00 Mn |
| 3 | Medline | 30.57 Bn | 36.41 Bn | 1.84 Bn | 239.00 Mn |
| 4 | Resmed | 28.04 Bn | 26.38 Bn | 890.98 Mn | 398.73 Mn |
| 5 | West Pharmaceutical Services | 23.76 Bn | 23.24 Bn | 296.40 Mn | 135.40 Mn |
| 6 | Solventum | 13.40 Bn | 13.40 Bn | 1.10 Bn | 13.00 Mn |
| 7 | Cooper Companies | 13.18 Bn | 13.04 Bn | 735.40 Mn | -77.90 Mn |
| 8 | Align Technology | 12.72 Bn | 11.66 Bn | 736.59 Mn | 112.77 Mn |
| 9 | Baxter International | 10.71 Bn | 8.67 Bn | 891.00 Mn | -17.00 Mn |
| 10 | Envista Holdings | 4.04 Bn | 2.96 Bn | 390.10 Mn | 38.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 38.70 Mn |
| Dec 31, 2025 | 32.90 Mn |
| Sep 26, 2025 | -30.30 Mn |
| Jun 27, 2025 | 26.40 Mn |
| Mar 28, 2025 | 18.00 Mn |
| Dec 31, 2024 | 1.20 Mn |
| Sep 27, 2024 | 8.20 Mn |
| Jun 28, 2024 | -1.15 Bn |
| Mar 29, 2024 | 23.60 Mn |
| Dec 31, 2023 | -217.40 Mn |
| Sep 29, 2023 | 21.50 Mn |
| Jun 30, 2023 | 51.90 Mn |
| Mar 31, 2023 | 43.80 Mn |
| Dec 31, 2022 | 73.50 Mn |
| Sep 30, 2022 | 49.60 Mn |
| Jul 1, 2022 | 44.50 Mn |
| Apr 1, 2022 | 70.40 Mn |
| Dec 31, 2021 | 42.50 Mn |
| Oct 1, 2021 | 80.20 Mn |
| Jul 2, 2021 | 79.00 Mn |